THE CIGNA GROUP (CI) Stock News
NYSE:CI - New York Stock Exchange, Inc. - US1255231003 - Common Stock
CI Latest News and Analysis
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
This year's JPMorgan health-care conference took place a month after UnitedHealthcare CEO Brian Thompson was fatally shot in New York City.
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
Many stocks flashed buy signals as the major indexes rose to or above key levels.
Noteworthy Thursday Option Activity: CI, BBWI, TSN
Interesting CI Put And Call Options For March 21st
UnitedHealth Q4 Earnings: Revenue Falls Short, Medical Ratio Rises To 85.5%, Stock Falls
On Thursday, UnitedHealth Group (NYSE:UNH) reported the fourth-quarter 2024 earnings and reaffirmed 2025 guidance. The company reported adjusted EPS of $6.81, up from $6.16 a year ago, beating the consensus of $6.72. Revenues increased 6.8% year over year to $100.8 billion, missing the consensus of $101.76 billion. Fourth-quarter adjusted earnings from operations of $8.3 billion exclude the cyberattack direct response costs and South American impacts. The full-year medical care ratio was 85.5% c
Can Integrated Healthcare Stocks Succeed in Public Markets?
An integrated healthcare model sees healthcare providers merge with health insurers. While CVS Health proves it can't be done, UnitedHealth may prove it can.
FTC accuses CVS, Cigna, and UnitedHealth of marking up cancer, HIV drugs
The Federal Trade Commission said the companies made $7.3 billion over five years from the inflated drug prices
FTC alleges PBMs cost consumers $7.3 billion marking up drug prices
The FTC released a 60-page report Tuesday targeting the biggest three pharmacy benefit managers, claiming the companies hiked the prices of specialty drugs to generate $7.3 billion in revenue from 2017 to 2022.
FTC releases second report on PBM price hikes of specialty drugs
The FTC released a 60-page report Tuesday targeting the biggest three pharmacy benefit managers, claiming the companies hiked the prices of specialty drugs to generate $7.3 billion in revenue from 2017 to 2022.
FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
The FTC said UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts marked up prices by hundreds or thousands of percent.
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S. Federal Trade Commission said on Tuesday. From 2017 to 2022, the companies -- UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts -- marked up prices at their affiliated pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue in excess of the acquisition costs of the drugs, the FTC said in its second report on the industry.
FTC Accuses CVS, Cigna, UnitedHealth of Abusing Middleman Role
Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost on dozens of specialty generic drugs, bringing in more than $7.3 billion in excess revenue over six years, the Federal Trade Commission said in a report on the drug middlemen.
MarketBeat Week in Review – 01/06 - 01/10
Stocks continued to slide after a hot jobs report sent bond yields higher, lowered expectations for future rate cuts, and keeps inflation and earnings in focus
CMS expects 4.33% increase in Medicare Advantage rates in 2026
The Centers for Medicare & Medicaid Services, or CMS, released the Calendar Year 2026 Advance Notice for the Medicare Advantage, or MA, and ...
The Cigna Group Foundation Supports Mental Health and Housing Stability for Veterans, Announcing First Round of Grant Recipients
/PRNewswire/ -- The Cigna Group Foundation announced today 22 recipients for the first year of its new grant program that aims to improve veteran mental health...
How Cigna Remains at the Top of the Health Insurance Food Chain
The Cigna Group has been agile and nimbly navigating the trends in managed care as it unloaded its Medicare Advantage business before the storm hit its peers.
The largest health insurance companies that control nearly 75% of the market, ranked
Over the past few years the health insurance industry has experienced a series of major mergers and acquisitions, further consolidating power into the hands of a few dominant companies — leaving Americans with fewer options.
Here's Why Cigna (CI) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
